S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?

Acrivon Therapeutics (ACRV) Earnings Date, Estimates & Call Transcripts

$9.61
-0.38 (-3.80%)
(As of 04/15/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

ACRV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ACRV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Acrivon Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.89)($0.89)($0.89)
Q2 20241($0.58)($0.58)($0.58)
Q3 20241($0.57)($0.57)($0.57)
Q4 20241($0.59)($0.59)($0.59)
FY 20244($2.63)($2.63)($2.63)

ACRV Earnings Date and Information

Acrivon Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Acrivon Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
11/9/2023Q3 2023($0.72)($0.66)+$0.06($0.66)--
8/11/2023Q2 2023($0.65)($0.63)+$0.02($0.63)--
5/9/2023Q1 2023($0.64)($0.58)+$0.06($0.58)--
3/28/2023Q4 2022($1.10)($0.80)+$0.30($0.80)--
12/15/2022Q3 2022($2.44)($5.17)($2.73)($5.17)--

Acrivon Therapeutics Earnings - Frequently Asked Questions

When is Acrivon Therapeutics's earnings date?

Acrivon Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on ACRV's earnings history.

How much profit does Acrivon Therapeutics generate each year?

Acrivon Therapeutics (NASDAQ:ACRV) has a recorded net income of -$60.39 million. ACRV has generated -$2.73 earnings per share over the last four quarters.

What is Acrivon Therapeutics's EPS forecast for next year?

Acrivon Therapeutics's earnings are expected to grow from ($3.42) per share to ($3.36) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ACRV) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners